Release of a product of growth arrest-specific gene 6 from rat platelets  by Ishimoto, Yoshikazu & Nakano, Toru
Release of a product of growth arrest-speci¢c gene 6 from rat platelets
Yoshikazu Ishimoto, Toru Nakano*
Discovery Research Laboratories, Shionogi p Co., Ltd., 5-12-4 Sagisu Fukushima-ku, Osaka 553-0002, Japan
Received 17 November 1999; received in revised form 24 December 1999
Edited by Shozo Yamamoto
Abstract A product of growth arrest-specific gene 6 (Gas6) is
known to be synthesized by growth-arrested cells. In this study,
we found that several rat tissues including platelets contain Gas6
and activation of the platelets with thrombin provoked the release
of Gas6. ADP and collagen, which as well as thrombin
stimulated release of ATP from platelets, also enhanced the
release of Gas6, suggesting that the mechanism of its release was
similar to that of ATP release. This study provides the first
evidence of growth arrest-independent secretion of Gas6 and
suggests the involvement of Gas6 in vascular diseases as well as
hemostasis.
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1. Introduction
Growth arrest-speci¢c gene 6 (gas6) was initially identi¢ed
as a gene whose expression in ¢broblasts increased during the
growth-arrested state [1]. Thereafter, some biological activities
of the product of gas6 (Gas6) have been reported. One is
stimulation of cell proliferation. We puri¢ed Gas6 as a protein
which potentiated cell proliferation mediated by Ca2-mobi-
lizing receptors [2]. Gas6 was also reported to stimulate pro-
liferation of ¢broblasts [3]. Another Gas6 activity is the pre-
vention of cell death induced by serum deprivation [3,4].
These activities of Gas6 were similar to those of growth fac-
tors activating receptor tyrosine kinases. Indeed, it was clari-
¢ed that Gas6 became bound to and stimulated receptor ty-
rosine kinases, Axl, Sky and Mer [5^8]. Therefore, the above
biological activities are very likely to be mediated by activa-
tion of tyrosine kinases.
Gas6 has a homology to protein S, a negative regulator of
blood coagulation, and is composed of three structurally dis-
tinct domains, the Gla domain, epidermal growth factor-like
repeat and C-terminal domain [1]. The Gla domain is rich in
Q-carboxyglutamic acid (Gla) residues and found in some
blood coagulation factors. The function of the Gla domain
in the coagulation factors is thought to be the mediation of
their Ca2-dependent binding to negatively charged phospho-
lipids. In a previous paper, we demonstrated that Gas6 is
bound to a negatively charged phospholipid, phosphatidylser-
ine (PS), and that Gas6 links receptor-expressing cells to PS-
exposing surfaces [9]. Thus, Gas6 may function as a cell ad-
hesion molecule in addition to a growth factor.
As described above, the production and secretion of Gas6
have been reported to be upregulated when cell proliferation
is prohibited. In this study, however, we found that rat plate-
lets, which do not proliferate, possess Gas6 and that activa-
tion of the platelets with thrombin, ADP or collagen can
stimulate the release of Gas6 from them. This ¢nding suggests
that Gas6 is involved in vascular diseases such as atheroscle-
rosis as well as hemostasis.
2. Materials and methods
2.1. Preparation of Gas6 and anti-rat Gas6 IgG
Recombinant rat Gas6 and anti-rat Gas6 were prepared as de-
scribed previously [10].
2.2. Preparation of rat tissue samples and immunoblotting
Tissues of male Sprague^Dawley rats were homogenized in a sam-
ple bu¡er of sodium dodecyl sulfate (SDS)^polyacrylamide gel elec-
trophoresis (SDS^PAGE). Insoluble substances were removed by cen-
trifugation and protein concentrations in the supernatants were
measured. The proteins extracted from each tissue (10 Wg/lane) were
separated with SDS^PAGE and transferred onto polyvinylidene di-
£uoride membranes. Gas6 on the membranes was visualized using
anti-rat Gas6 IgG.
2.3. Preparation of rat platelets
Blood was drawn from the abdominal aorta of anesthetized male
Sprague^Dawley rats into a syringe containing 3.8% trisodium citrate
(1:9, v/v). The blood was centrifuged at 160Ug for 10 min at room
temperature to obtain platelet-rich plasma (PRP). The PRP was over-
laid on 0.5 ml of 40% bovine serum albumin (BSA) in a tube, and
centrifuged at 1200Ug for 25 min at room temperature. The platelets
were resuspended in the suspension bu¡er (140 mM NaCl, 2.7 mM
KCl, 12 mM NaHCO3, 0.4 mM NaH2PO4, 0.8 mM MgCl2, 5 mM
glucose, 10 mM HEPES, 1 mM CaCl2, 0.1% BSA, pH 7.4) and pu-
ri¢ed with a column of Sepharose 2B. The platelets were suspended at
1U109/ml.
2.4. Stimulation of platelets
Thrombin (Sigma), ADP (Sigma), collagen (Sigma) or calcium ion-
ophore A23187 (Sigma) was added to 400 Wl of platelets, which were
then incubated at 37‡C. Next, PGE1 (2.5 Wg/ml) was added to stop the
reactions. The samples were centrifuged at 1000Ug for 0.5 min at
room temperature and Gas6 in the supernatant was analyzed by im-
munoblotting or enzyme-linked immunosorbent assay (ELISA).
2.5. Quanti¢cation of Gas6
ELISA plates (Corning) were coated with 100 Wl/well of anti-rat
Gas6 IgG dissolved in Tris-bu¡ered saline (TBS) (10 mM Tris^HCl,
pH 7.4, 150 mM NaCl). The plates were incubated for 18 h at 4‡C
and then blocked with 3% BSA in TBS for 2 h at room temperature.
The wells were washed with TBS containing 0.05% Tween-20 and
incubated with samples or Gas6. Gas6 bound to the wells was deter-
mined using biotinylated anti-rat Gas6 IgG and peroxidase-conju-
gated streptavidin (Zymed).
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2.6. ATP measurement
Platelets and luminescence reagent (20 Wl ATP Assay Mix; Sigma)
were placed in a cuvette, and luminescence and platelet aggregation
were measured simultaneously with an aggregometer (Whole Blood
Aggregometer, Chrono-Log). ATP released from the platelets was
quanti¢ed by addition of 2 nmol of ATP to the samples as an internal
control at the end of the experiment.
3. Results and discussion
In order to investigate the tissue distribution of Gas6, we
analyzed several rat tissues for Gas6 by immunoblotting using
anti-rat Gas6 IgG. As shown in Fig. 1, Gas6 existed in several
but not all rat tissues. Skin, lung, aorta, thymus, spleen, bone
marrow and platelet contained signi¢cant amounts of Gas6.
Gas6 has been reported to be synthesized and released when
cell proliferation is inhibited. However, platelets do not pos-
sess the ability to proliferate. We were thus interested in
whether the Gas6 in the platelets would be released on ad-
equate stimulation.
Platelets release several substances such as ATP, platelet
factors and platelet-derived growth factor upon stimulation
with agonists like thrombin, ADP or collagen [11]. Thus, we
examined the release of Gas6 from rat platelets stimulated
with thrombin. As shown in Fig. 2, thrombin stimulation of
the rat platelets increased the levels of Gas6 in the superna-
tant.
Fig. 3 shows the results of quanti¢cation of Gas6 released
from rat platelets using ELISA. Fig. 3A demonstrates that
Gas6 release was dependent on the concentration of throm-
bin, with half-maximal release occurring at approximately
0.8 U/ml thrombin. The time course of the release of Gas6
from the thrombin-stimulated rat platelets showed that the
release was completed in 0.5 min (Fig. 3B).
As shown in Fig. 4A, other platelet agonists, ADP and
collagen also induced secretion of Gas6 from rat platelets
while the released Gas6 was much less than that released by
thrombin stimulation. Fig. 4B shows the release of ATP from
the platelets. The proportions of Gas6 release and ATP re-
lease were very similar, suggesting that both are mediated by
common intracellular mechanisms. This was also supported
by the ¢nding that both Gas6 release and ATP release were
similarly induced by calcium ionophore A23187, which acti-
vates platelets by increasing intracellular Ca2 concentrations
(Fig. 4A,B).
The production and secretion of Gas6 from cells has been
reported to be enhanced when cell proliferation is arrested [1].
Although Gas6 may be produced by growth-arrested cells in
order to inhibit growth cell death induced by the growth ar-
rest [4,5], the true purpose of growth arrest-speci¢c produc-
tion of Gas6 has not been proved.
In this study, we ¢rst demonstrated that Gas6 is present in
and is released from non-proliferation cells, i.e. platelets. It is
known that the stimulation of platelets with many agonists
induces release of several substances from the platelets, in-
volving ATP, platelet factors or platelet-derived growth fac-
tor, which further enhance platelet aggregation, blood coagu-
lation or proliferation of cells in the vessel walls [11]. The
release of growth factors from the platelets is thought to be
related to the progress of vascular diseases such as atheroscle-
rosis and restenosis [12]. Since Gas6 stimulates cell prolifera-
tion of vascular smooth muscle cells in vitro [2], the Gas6
released from the stimulated platelets may also be involved
in these diseases. Melaragno et al. reported the increased ex-
pression of Axl after vascular injury [13].
On the other hand, our previous study suggested that Gas6
Fig. 1. Tissue distribution of Gas6. The proteins extracted from
each rat tissues (10 Wg/lane) were separated with SDS^PAGE and
transferred onto polyvinylidene di£uoride membranes. Gas6 on the
membranes was visualized using anti-rat Gas6 IgG. The bands ex-
cept Gas6 are non-speci¢c signals which were observed even in the
absence of ¢rst antibody.
Fig. 2. Secretion of Gas6 from platelets stimulated by thrombin.
Rat platelets, 400 Wl, were incubated for 5 min at 37‡C in the pres-
ence (T) or absence (C) of 5 U/ml thrombin. After the incubation,
PGE1 was added to stop the activation, then the sample was centri-
fuged. The supernatants were separated with SDS^PAGE and trans-
ferred onto polyvinylidene di£uoride membranes. Gas6 on the mem-
branes was visualized using anti-rat Gas6 IgG.
Fig. 3. Dose-dependency and time course of Gas6 secretion from
platelets stimulated by thrombin. (A) The platelets were stimulated
with various concentrations of thrombin for 5 min. (B) The platelets
were stimulated with 5 U/ml thrombin for various periods. The
Gas6 concentration in the supernatants of platelets stimulated by
thrombin was quanti¢ed by ELISA. Data were means þ S.D. (n = 3).
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may function as an adhesion molecule which links the cells
expressing Gas6 receptor and the cells expressing PS on the
surfaces [9], while it has also been reported that Gas6 inhib-
ited the adhesion of neutrophils to endothelial cells [14]. PS is
mainly present only in the inner lea£et of the cell membranes
[15]. However, PS emerges to the outer surface of the cell
membranes upon platelet activation as well as apoptosis
[16,17]. Therefore, a part of the Gas6 released from the
platelets may bind to PS exposed on activated platelets,
from which it is released. Gas6 bound to platelet surfaces
may enhance coagulation by stimulating adhesion of the acti-
vated platelets to endothelial cells. Another possible role of
platelet surface-associated Gas6 may be a marker which is
recognized by macrophages that take up PS-expressing cells
and inhibit excessive coagulation.
In conclusion, the ¢ndings described in this study suggest
the involvement of Gas6 released from the platelets in vascu-
lar diseases such as atherosclerosis and intimal thickening, as
well as in the regulation of hemostasis.
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Fig. 4. Secretion of Gas6 (A) and ATP (B) from platelets stimulated
by various stimulants. (A) The platelets were incubated for 5 min
with thrombin, ADP, collagen, A23187 or none (C). The Gas6 con-
centration in the supernatants was quanti¢ed by ELISA. Data were
means þ S.D. (n = 3). (B) Platelets and luminescence reagent (20 Wl)
were placed in a cuvette, and luminescence and platelet aggregation
were measured simultaneously in an aggregometer. Maximum con-
centration of ATP released from the platelets was quanti¢ed by ad-
dition of 2 nmol of ATP to the samples as an internal control at
the end of the experiment. Data were means þ S.D. (n = 3).
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